Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Orange Book Patents
Across 1 drug with upcoming expirations
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 3
R&D Momentum
27/100
Pipeline Velocity
6/100
Trial Completion Rate
71/100
Pipeline Concentration
33/100
Pipeline Freshness
97/100
Strategic Signals
Activity
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Regulatory
Phoslo — PHOSLO
Application NDA019976 (NDA)
Phoslo — PHOSLO
Application NDA021160 (NDA)
Phoslo — PHOSLYRA
Application NDA022581 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)